Introduction The psilocybin industry in Oregon has recently been regulated by the Oregon Health Authority Public Health Division (“OHA” or “Authority”) under its new section, the Oregon Psilocybin Services (OPS). OHA and is now accepting licensing applications for psilocybin businesses and services and one of the key requirements for potential psilocybin manufacturers, service centers, facilitators, and laboratories is to submit
Consumer-facing businesses in emerging industries face extensive risks, especially when the core business service constitutes a potentially dangerous or hazardous activity. This maxim holds true for psilocybin service centers in Oregon, where customers pay to receive cutting-edge therapies involving controlled substances. Written liability waivers represent one of the best ways for psilocybin service centers in Oregon to mitigate their risks. What Legal
Oregon leads the nation in building a regulated psilocybin industry. As this industry grows and matures, operators must remain mindful of important intersections between regulations and intellectual property. Background: Oregon Psilocybin Services Act & Finalized Rules The Oregon Psilocybin Services Act Ballot Measure 109 (M109), otherwise known as the Oregon Psilocybin Services Act (the “OPSA”), established a legal basis for
Contracting Considerations for Residency Requirements under the Oregon Psilocybin Services Act (ORS 475A)
Oregon approved Ballot Measure 109 (M109) and put into place the Oregon Psilocybin Services Act (the “Act”) to allow for consumption of psilocybin at certain licensed service centers through licensed facilitators and administrators in the State of Oregon. It was voted into law in November 2020 and is codified in the Oregon Revised Statutes under ORS 475A. Following a two-year
Similar to the packaging and labeling requirements for cannabis products, Oregon’s psilocybin manufacturers have to comply with strict packaging and labeling rules for their psilocybin products. Psilocybin remains a Schedule 1 Controlled Substance at the Federal level, and the packaging and labeling regulations ensure that minors and other unintended persons don’t access psilocybin products. However, unlike the adult-use cannabis industry,
Oregon Psilocybin Services requires manufacturers to include a Product Information Document when they move any psilocybin product to licensed service centers.
Emerging psilocybin businesses should carefully consider the proposed advertising restrictions, before they go about building their brand assets (logo, brand name, website, etc.) and putting together plans for promoting their psilocybin products and services.
It is crucial to understand the residency requirements for various psilocybin-related operational licenses, as Oregon, the first state in the United States to establish a psilocybin regulatory framework, starts accepting applications for psilocybin licenses beginning January 2, 2023.
Oregon is the first state in the U.S. to create a regulatory framework for psilocybin services. Starting January 2, 2023, applicants can apply for various psilocybin-related operational licenses, including psilocybin manufacturer licenses.
As psychedelic therapies continue to develop as contemplative businesses and in research programs commencing at both the state and federal levels in the United States, we are naturally compelled to learn from similar or semi-similar developments in the cannabis business regarding what has worked and what has not worked in addressing federally prohibited substances, their potential risks, potential benefits and